Báo cáo khoa học: Restriction point control of the mammalian cell cycle via the cyclin E/Cdk2:p27 complex doc

Restriction point control of the mammalian cell cycle via the cyclin E/Cdk2:p27 complex ´ ´ Riaan Conradie1, Frank J Bruggeman2, Andrea Ciliberto3, Attila Csikasz-Nagy4, Bela Novak5, Hans V Westerhoff2,6 and Jacky L Snoep1,2,6 Triple J Group for Molecular Cell Physiology, Department of Biochemistry, Stellenbosch University, Matieland, South Africa Molecular Cell Physiology & Netherlands Institute for Systems Biology, Vrije Universiteit, Amsterdam, The Netherlands FIRC Institute of Molecular Oncology Foundation, Milan, Italy University of Trento Centre for Computational and Systems Biology, Povo (Trento), Italy Oxford Centre for Integrative Systems Biology, University of Oxford, UK Manchester Centre for Integrative Systems Biology, Manchester Interdisciplinary Biocentre, The University of Manchester, UK Keywords cell cycle; kinetic modeling; metabolic control analysis; restriction point; systems biology Correspondence J L Snoep, Triple J Group for Molecular Cell Physiology, Department of Biochemistry, Stellenbosch University, Private Bag X1, Matieland 7602, South Africa Fax: +272 1808 5863 Tel: +272 1808 5844 E-mail: jls@sun.ac.za Note The mathematical model described here has been submitted to the JWS Online Cellular Systems Modelling Database and can be accessed at http://jjj.biochem.sun.ac.za/ database/conradie/index.html free of charge (Received 14 May 2009, revised 21 October 2009, accepted 30 October 2009) doi:10.1111/j.1742-4658.2009.07473.x Numerous top-down kinetic models have been constructed to describe the cell cycle These models have typically been constructed, validated and analyzed using model species (molecular intermediates and proteins) and phenotypic observations, and therefore not focus on the individual model processes (reaction steps) We have developed a method to: (a) quantify the importance of each of the reaction steps in a kinetic model for the positioning of a switch point [i.e the restriction point (RP)]; (b) relate this control of reaction steps to their effects on molecular species, using sensitivity and co-control analysis; and thereby (c) go beyond a correlation towards a causal relationship between molecular species and effects The method is generic and can be applied to responses of any type, but is most useful for the analysis of dynamic and emergent responses such as switch points in the cell cycle The strength of the analysis is illustrated for an existing mammalian cell cycle model focusing on the RP [Novak B, Tyson J (2004) J Theor Biol 230, 563–579] The reactions in the model with the highest RP control were those involved in: (a) the interplay between retinoblastoma protein and E2F transcription factor; (b) those synthesizing the delayed response genes and cyclin D/Cdk4 in response to growth signals; (c) the E2F-dependent cyclin E/Cdk2 synthesis reaction; as well as (d) p27 formation reactions Nine of the 23 intermediates were shown to have a good correlation between their concentration control and RP control Sensitivity and co-control analysis indicated that the strongest control of the RP is mediated via the cyclin E/Cdk2:p27 complex concentration Any perturbation of the RP could be related to a change in the concentration of this complex; apparent effects of other molecular species were indirect and always worked through cyclin E/Cdk2:p27, indicating a causal relationship between this complex and the positioning of the RP Abbreviations DRG, delayed response genes; ERG, early response genes; MCA, metabolic control analysis; Rb, retinoblastoma protein; RP, restriction point FEBS Journal 277 (2010) 357–367 ª 2009 The Authors Journal compilation ª 2009 FEBS 357 Restriction point control of the mammalian cell cycle R Conradie et al Introduction Arthur Pardee [1] defined the restriction point (RP) as the apparent switch point in the late G1-phase, beyond which normal cells would only progress when supplied with a sufficient, mitogen containing culture medium Once the cell has transgressed the RP, the necessity of a mitogen (i.e growth factor) containing medium is relieved and cells commit to replicate their DNA (S-phase) and complete the remainder of the division cycle autonomously [2,3] Cells in the G1phase that have not yet passed RP, monitor their environment and own size to determine whether they are ready to commit to S-phase entry and division cycle completion or, in contrast, enter the resting G0-phase [2], where most non-cancerous somatic mammalian cells spend their lifetime Disregulation of the RP has been linked to several disease states, most notoriously cancer [1,4], and quantification of the contribution of the different reaction steps in the cell cycle to the control of the RP would be important for drug target identification studies and for understanding the action mechanism of existing, RP affecting drugs Abrupt cell cycle transitions (e.g G1/S) are properties of the complete underlying control system, which can be described without the need to introduce hypothetical regulatory proteins or hard code a decision event [5,6] Numerous kinetic models that incorporate the existing knowledge of the molecular mechanism of the RP have been constructed [5,7–9] Novak and Tyson [5] constructed their kinetic model on the RP of the mammalian cell cycle using a yeast-like core model of the cyclin–Cdk interactions (emphasizing the deep similarities of the Cdk-regulatory systems of yeast and mammalian cells) They extended this core model with kinetic modules for the growth factor sensing machinery of mammalian cells; the retinoblastoma and E2F transcription factor interactions and the antagonism between the cyclin-dependent kinase inhibitor (p27Kip1) and cyclin A/Cdk2 and cyclin E/Cdk2 With their kinetic model, Novak and Tyson could account for the findings obtained in the experiments by Zetterberg and Larsson [10], which demonstrated the existence of RP and positioned it somewhere in the G1-phase (a) cells pulse treated (1 h) with cycloheximide early in the cell cycle (before RP) immediately suffer a long delay in the cell division cycle; (b) cells treated late in the division cycle finish the current cycle similar to untreated cells but are significantly delayed in the subsequent division cycle; and (c) cells treated directly after the RP not suffer any delays in the current or subsequent division cycles 358 Kinetic models that are constructed on the basis of known biochemical information about the system and its components are routinely used to integrate this knowledge and compare the resulting simulations with experimental observations More extensive analysis methods are necessary to quantify the importance of each of the reaction steps for the systemic behavior Metabolic control analysis (MCA) [11,12] is a rigorous framework that enables the assessment of how a biological function is controlled by the various molecular processes in the cell sustaining that function MCA has been used predominantly to analyse the control distribution in steady states, although the theory has been generalized for systems with dynamic behavior [13–17] In this contribution, we develop and implement an extension to MCA that can be used not only to quantify the control of system variables, but also to infer by which molecular species this control was elicited Our approach is well suited for systems biology studies where the primary goal is to come to a quantitative understanding of systemic properties (such as the emergent RP in the mammalian cell cycle) in terms of the multitude of reaction steps and interactions between the cell’s molecular parts (e.g cell cycle proteins) [18] Numerous studies have recognized the need for theoretical approaches in molecular biology [19– 24] Our novel framework would be useful for molecular and systems biologists to determine which reactions exert important control on a high-level system property, and explain by which molecular species these reaction steps exert their control Applying our approach to the RP, as modeled in the kinetic model developed by Novak and Tyson [5], revealed that the control of RP was distributed over the different reaction steps in the network The highest control was exerted by the reactions responsible for: (a) the interaction between retinoblastoma protein (Rb) and E2F transcription factor; (b) synthesis of delayed response genes (DRGs) and cyclin D/Cdk4 in response to growth signals; (c) the E2F-dependent cyclin E/Cdk2 synthesis reaction; and (d) the p27 formation reactions In addition, our analysis revealed that RP control was exerted via the cyclin E/Cdk2:p27 complex Independent of which reaction step or which molecular species was perturbed, all of the effects on the RP could be explained via an effect of the perturbation on cyclin E/Cdk2:p27 The mathematical model described here has been submitted to the JWS Online Cellular Systems Modelling Database and can be accessed at http:// FEBS Journal 277 (2010) 357–367 ª 2009 The Authors Journal compilation ª 2009 FEBS R Conradie et al Restriction point control of the mammalian cell cycle Table Mammalian cell cycle model [5] kinetics Reaction number Rate equations 10 11 12 13 14 15 16 17 18 19 v(1) ẳ k16 ặ ERG(t) v(2) ẳ k18 ặ DRG(t) v(3) ẳ K10 ặ CD(t) v(4) ẳ K10 ặ CYCD(t) v(5) ẳ K25 ặ p27(t) ặ CYCE(t) v(6) ẳ K25 Æ p27(t) Æ CYCA(t) v(7) ¼ k24 Æ CYCD(t) Æ p27(t) v(8) ẳ k24r ặ CD(t) v(9) ẳ K30 ặ Cdc20(t) ặ CYCA(t) v(10) ẳ K30 ặ Cdc20(t) ặ CA(t) v(11) ẳ K25R ặ CE(t) v(12) ẳ K25R ặ CA(t) v(13) ẳ V8 ặ CE(t) v(14) ẳ V8 ặ CYCE(t) v(15) ẳ V6 ặ p27(t) v(16) ẳ V6 ặ CE(t) v(17) ẳ V6 ặ CD(t) v(18) ẳ V6 ặ CA(t) v(19) ẳ V2 ặ CYCB(t) K3a ỵ K3 Cdc20tịị1 Cdh1tịị v 20ị ẳ J3 Cdh1tị ỵ V4 Cdh1tị v 21ị ẳ J4 ỵ Cdh1tị v(22) ẳ K34 ặ PPX(t) K31 CYCBtị1 IEPtịị v 23ị ẳ J31 IEPtị ỵ K32 PPXtị IEPtị v 24ị ẳ J32 ỵ IEPtị v(25) ẳ K12 ặ Cdc20T(t) K13 IEPtịCdc20Ttị Cdc20tịị v 26ị ẳ J13 Cdc20tị ỵ Cdc20Ttị K14 Cdc20tị v 27ị ẳ J14 ỵ Cdc20tị v(28) ẳ K12 ặ Cdc20(t) v(29) ẳ E2F-Rb(t)(K20(CYCDT ặ LD + LA ặ CYCA(t) + LB ặ CYCB(t) + LE ặ CYCE(t))) v(30) ẳ P-E2F-Rb(t)(K20(CYCDT Æ LD + LA Æ CYCA(t) + LB Æ CYCB(t) + LE ặ CYCE(t)))   Rbtị ỵ E2F-Rbtị ỵ P-E2F-Rbtị > 0:8; 0; v 31ị ẳ K27 MASStị If PP-Rbtị ỵ Rbtị ỵ E2F-Rbtị ỵ P-E2F-Rbtị v(32) ẳ K28 ặ GM(t) v(33) ẳ eps(t) ặ MU ặ GM(t) epstị k15 v 34ị ẳ  2 DRGtị ỵ J15 v(35) ẳ eps(t)(K11a + K11 ặ CYCB(t)) v(36) ẳ eps(t) ặ K29 ặ E2F(t) ặ MASS(t) v(37) ẳ eps(t) ặ K33 v(38) ẳ eps(t)(K7a+K7 ặ E2F(t)) v(39) ẳ eps(t) ặ K9 ặ DRG(t) v(40) ẳ eps(t) Æ K5  2 DRGðtÞ C Bk17 J17 v 41ị ẳ epstị @  ỵ k17a ERGtịA 2 DRGtị ỵ J17  2 K1 CYCBtị C B J1 v 42ị ẳ epstị @  ỵ K1aA CYCBtị ỵ J1 v(43) ẳ Rb(t)(K20(CYCDT ặ LD + LA ặ CYCA(t) + LB ặ CYCB(t) + LE ặ CYCE(t))) v(44) ẳ PP-Rb(t)(K19a(PP1T ) PP1A) + K19 ặ PP1A) v(45) ẳ E2F-Rb(t) ặ K26R v(46) ¼ E2F(t)(K23a + K23(CYCA(t) + CYCB(t))) 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 FEBS Journal 277 (2010) 357–367 ª 2009 The Authors Journal compilation ª 2009 FEBS 359 Restriction point control of the mammalian cell cycle R Conradie et al Table (Continued ) Reaction number Rate equations 47 48 49 50 51 52 v(47) v(48) v(49) v(50) v(51) v(52) ẳ ẳ ẳ ẳ ẳ ẳ P-E2F(t) ặ K22 E2F(t) Ỉ Rb(t) Ỉ K26 P-E2F-Rb(t) Ỉ K26R Rb(t) Æ P-E2F(t) Æ K26 P-E2F-Rb(t) Æ K22 E2F-Rb(t)(K23a + K23(CYCA(t) + CYCB(t))) Model parameters in [5]: k15 ¼ 0.025; k16 ¼ 0.025; J15 ¼ 0.1; k17a ¼ 0.035; k17 ¼ 1.; J17 ¼ 0.3; k18 ¼ 1.; K9 ¼ 0.25; K10 ¼ 0.5; k24 ¼ 100.; k24r ¼ 1.; K7a ¼ 0.; K7 ¼ 0.06; K8a ¼ 0.01; K8 ¼ 0.2; K25 ¼ 100.; K25R ¼ 1.; J8 ¼ 0.1; YE ¼ 1.; YB ¼ 0.05; K29 ¼ 0.005; K30 ¼ 2.; K1a ¼ 0.01; K1 ¼ 0.06; J1 ¼ 0.1; K2a ¼ 0.005; K2 ¼ 2.; K2aa ¼ 0.1; K5 ¼ 2.; K6a ¼ 1.; K6 ¼ 10.; HE ¼ 0.5; HB ¼ 1.; HA ¼ 0.5; LD ¼ 3.3; LE ¼ 5.; LB ¼ 5.; LA ¼ 3.; K20 ¼ 1.; K19a ¼ 0.; K19 ¼ 2.; K21 ¼ 1.; PP1T ¼ 1.; FE ¼ 25.; FB ¼ 2.; K3a ¼ 0.75; K3 ¼ 14.; J3 ¼ 0.01; J4 ¼ 0.01; K4 ¼ 4.; GE ¼ 0.; GB ¼ 1.; GA ¼ 0.3; K33 ¼ 0.005; K34 ¼ 0.005; K31 ¼ 0.07; K32 ¼ 0.18; J31 ¼ 0.01; J32 ¼ 0.01; K11a ¼ 0.; K11 ¼ 0.15; K12 ¼ 0.15; K13 ¼ 0.5; K14 ¼ 0.25; J13 ¼ 0.005; J14 ¼ 0.005; K22 ¼ 0.1; K23a ¼ 0.0005; K23 ¼ 0.1; K26 ¼ 1000.; K26R ¼ 20.; K27 ¼ 0.02; K28 ¼ 0.02; MU ¼ 0.0061 Definitions and steady-state relations: PP1T PP1A ẳ K21 FE CYCAtị ỵ CYCEtịị ỵ FB CYCBtịị ỵ V2 ẳ K2aa Ỉ Cdc20(t) + K2a Ỉ (1)Cdh1(t)) + K2 Ỉ Cdh1(t) V4 ẳ K4 ặ (GA ặ CYCA(t) + GB Æ CYCB(t) + GE Æ CYCE(t)) V6 ¼ K6a + K6 Ỉ (HA Ỉ CYCA(t) + HB Ỉ CYCB(t) + HE ặ CYCE(t)) YE CYCAtị ỵ CYCEtịị ỵ YB CYCBtịị K8 V8 ẳ ỵ K8a CYCET ỵ J8 CYCET ¼ CE(t) + CYCE(t); CYCDT ¼ CD(t) + CYCD(t); CYCAT ¼ CA(t) + CYCA(t); P27T ¼ CA(t) + CD(t) + CE(t) + p27(t); eps(t) ¼ Event: MASS(t) = MASS(t) ⁄ 2, when Cdh1(t) crosses 0.2 from below ODEs and Initial conditions: CA’(t) = v(6) ) v(12) ) v(18) ) v(10), CA(0) = 0.0356927; CD’(t) = v(7) ) v(8) ) v(17) ) v(3), CD(0) = 0.010976; Cdc20¢(t) = v(26) ) v(27) ) v(28), Cdc20(0) = 0.00220177; CDc20T’(t) = v(35) ) v(25), Cdc20T(0) = 2.36733; Cdh1¢(t) = v(20) ) v(21), Cdh1(0) = 0.000653278; CE’(t) = v(5) ) v(11) ) v(13) ) v(16), CE(0) = 0.000542587; CYCA’(t) = v(36) ) v(9) ) v(6) + v(12) + v(18), CYCA(0) = 1.4094; CYCB’(t) = v(42) ) v(19), CYCB(0) = 2.72898; CYCD’(t) = v(39) + v(17) + v(8) ) v(7) ) v(4), CYCD(0) = 0.43929; CYCE’(t) = v(38) ) v(14) ) v(5) + v(11) + v(16), CYCE(0) = 0.0229112; DRG’(t) = v(41) ) v(2), DRG(0) = 0.900533; ERG’(t) = v(34) ) v(1), ERG(0) = 0.0121809; GM’(t) = v(31) ) v(32), GM(0) = 1.35565; IEP’(t) = v(23) ) v(24), IEP(0) = 0.154655; MASS’(t) = v(33), MASS(0) = 1.68776; P27¢(t) = v(40) + v(3) + v(8) ) v(15) ) v(5) ) v(6) ) v(7) + v(11) + v(12) + v(13) + v(10), P27(0) = 0.00922806; PPX’(t) = v(37) ) v(22), PPX(0) = 1; (var1) pp-RB’(t) = v(29) + v(30) + v(43) ) v(44), pp-RB(0) = 9.97574; (var2) E2F’(t) = v(29) + v(45) + v(47) ) v(46) ) v(48), E2F(0) = 0.989986; (var3) p-E2F’(t) = v(30) + v(49) + v(46) ) v(47) ) v(50), p-E2F(0) = 3.98594; (var4) Rb’(t) = v(44) + v(45) + v(49) ) v(48) ) v(50) ) v(43), Rb(0) = 0.000190871; (var5) E2F-Rb’(t) = v(51) + v(48) ) v(52) ) v(29) ) v(45), E2F-Rb(0) = 0.00478911; (var6) p-E2F-Rb’(t) = v(52) + v(50) ) v(51) ) v(30) ) v(49), p-E2F-Rb(0) = 0.0192822 jjj.biochem.sun.ac.za/database/conradie/index.html free of charge Model, methods and theory The model presented by Novak and Tyson [5] consisted of 18 ordinary differential equations (ODEs) and several algebraic equations Each of these ODEs were used, along with the wiring diagram of the mammalian cell cycle network, to distil 52 reaction steps from the network, such that each step formed a functional unit within the network The retinoblastoma and E2F transcription factor interactions which were coded as steady-state algebraic equations in the original model were coded explicitly as ODEs, increasing the number of ODEs to 23 (see Table 1) The reaction network of the cell cycle model is schematically represented in Fig 360 mathematica, version 6.0 (Wolfram Research, Champaign, IL, USA, http://www.wolfram.com/) was used for all simulations The ODEs were solved using the NDSolve function in combination with the EventLocator method to precisely locate events during the simulation A simulation result in which the RP and the different phases of the cell cycle are indicated is shown in Fig In the Novak and Tyson model, the variable cyclin E represents the cyclin E/Cdk2 complex (i.e cyclin E in its active form) It is therefore not possible to distinguish between active and inactive forms of cyclin E in the Novak and Tyson model MCA is a theoretical framework that can be used to calculate the importance of each of the steps in a reaction network for the systemic behavior, using so-called control coefficients [11,12] We used a perturbation method to calculate control coefficients by adding a multiplier to each of the 52 steps (a1 to a52) and FEBS Journal 277 (2010) 357–367 ª 2009 The Authors Journal compilation ª 2009 FEBS R Conradie et al A Restriction point control of the mammalian cell cycle C B D E F Fig The reaction network scheme of the mammalian cell cycle model The network consists of 52 reactions, which are grouped into six modules (A) A central component of the model is the antagonism between cyclin B and Cdh1 (reactions 19, 20, 21 and 42) This antagonistic nature of the cell cycle is found amongst all eukaryotes (B) Included in the mammalian cell cycle model are the early and delayed-response genes (ERG and DRG, respectively) In the scheme the steps responsible for ERG, DRG and cyclin D synthesis are reactions 34, 39 and 41 Growth factors bind to specific receptors found on the plasma membrane to subsequently stimulate an intracellular signal-transduction pathway that activates ERGs The ERGs then activate DRGs and cyclin D, which set the cell division cycle in motion (C) The retinoblastoma protein (Rb) is a general inhibitor of E2F (a transcription factor), and is distributed between an active, hypophosphorylated form (PP-Rb) and an inactive form The phosphorylation of Rb is induced by Cdk/cyclin complexes (D) P27, a cyclin-dependent kinase inhibitor in the G1-phase, also binds to cyclin A/Cdk2 (CYCA) and cyclin E/Cdk2 (CYCE) dimers to form inactive trimers (CA and CE, respectively, these steps occur within the cyclin–cyclin dependent kinase inhibitor module) Reactions are indicated by numbers; a white number on a black background denotes reactions that are allosterically regulated, reactions encircled by a dotted line are dependent on ribosome activity (eps factor in model reactions); the specific rate equation for each of the reaction steps is provided in Table perturbing each reaction individually (0.1 per million perturbation up and down) After each perturbation, the model was simulated until a new limit cycle was reached and then control coefficients for stationary behavior (e.g position of RP or the length of the G1-phase) were calculated and expressed as a fraction of the cell division cycle For nonstationary behavior (i.e time-dependent variables such as concentrations of metabolites or flux values for reaction steps), an exten- Fig Time course of the mammalian cell division cycle A time integration for 30 h is shown for six of the intermediates of the system The G1-, S/G2- and M-phases for one cell cycle are indicated in the graph The RP is also depicted in the G1-phase It should be noted that, in contrast to other switch points in the model, the RP is not a hard coded event (i.e it is not an explicit function, but rather an emergent property of the model), and it is empirically defined as the last time point where, upon cycloheximide (CHX) treatment, the cell would not finish the division cycle it started with The CHX treatment was mimicked in the model by reducing the translation efficiency of the ribosomes [e or Eps(t)], a parameter found in all synthesis steps of the model, from 1.0 to 0.5 This definition was taken from the original publication in which the model was described [5] sion of MCA was used that enables the determination of control coefficients as the system progresses through an arbitrary fixed interval of time (e.g the cell division cycle); a detailed description of the method is provided elsewhere [17] Results and Discussion Control of the RP We used a perturbation method to quantify the control of the respective reaction steps in a mammalian cell cycle model on the time of occurrence of the RP, CiRP The analysis revealed (Fig 3) that the control is distributed over the reaction network, with the majority of the reactions steps exerting a small to moderate control (jCiRP j < 1) Eight reaction steps exerted a high control (jCiRP j > 2) on the RP; four of which caused a delay (positive control), whereas the others advanced the RP (negative control) The CiRP for all reaction steps sums up to 0; this is to be expected on the basis of our definition of RP as a fraction of the cell division cycle The control coefficient of reaction step x on RP is the percentage change in the fraction of the cell cycle length at which RP occurs upon a 1% FEBS Journal 277 (2010) 357–367 ª 2009 The Authors Journal compilation ª 2009 FEBS 361 Restriction point control of the mammalian cell cycle R Conradie et al 17 21 30 15 47 16 38 29 39 41 CRP i 44 40 46 20 48 33 31 –2 –4 –6 Reaction number (i) change in the activity of x If we had defined the RP as an absolute time point, then the sum of control coefficients would add up to )1 (as they for the control on the cell division time) The four steps delaying the RP the most (i.e with the highest positive control values) are: (a) the breakRP down reaction of the DRG (Reaction 2, C2 $ 7); (b) the step involved in proteolysis of cyclin D in the cyclin D:p27 complex, releasing the cyclin dependent RP kinase inhibitor (p27), (Reaction 3, C3 $ 5); (c) the phosphatase reaction responsible for the dephosphoryRP lation of retinoblastoma (Reaction 44, C44 $ 5); and (d) the reaction step responsible for the synthesis of RP p27 (Reaction 40, C40 $3) The steps advancing the RP the most (i.e with the highest negative control values) are: (a) the synthesis reactions of the DRGs and cyclin D (Reactions 41 and RP RP 39, C41 $ À7 and C39 $ À5); (b) the cyclin mediated phosphorylation of retinoblastoma to release it from the retinoblastoma:E2F complex yielding free E2F (ReacRP tion 29, C29 $ À4); and (c) the reaction responsible for RP the production of cyclin E (Reaction 38, C38 $ À3) To identify the mechanism underlying the high control coefficients of these steps for RP, we first analyzed which molecular species showed the same control pattern as that observed for the RP A strong correlation between the control on RP and the concentration control coefficients of species directly involved in the molecular machinery governing the RP is to be expected To test this, we plotted the concentration control coefficients for the model variables against the RP control for each of the reaction steps (Fig 4) For nine of the 23 molecular species, a strong correlation was observed, with some species showing a positive correlation, whereas others have a negative correlation and all species have a different slope in the correlation 362 Fig The control exerted on the RP by the respective reaction steps (numbered as in Fig 1) is shown RP control is defined as the percentage change in the time point of occurrence of RP (as a fraction of total cell cycle time) upon a 1% change in activity of a reaction step A positive control of a reaction step indicates that an increase in the activity of the step delays the occurrence of RP plots (note that the y-axes between the plots differ) The nine variables that showed a strong correlation were cyclin A, cyclin D, cyclin E, cyclin E:p27 complex, p27, hyperphosphorylated retinoblastoma, E2F transcription factor, unphosphorylated retinoblastoma and unphosphorylated retinoblastoma bound to E2F transcription factor All of these species either reside in the early and DRG module, in the cyclin–cyclin-dependent kinase inhibitor module or the retinoblastoma– E2F transcription factor module (Fig 1, modules B, C and D) These are the same three modules that also contain the aforementioned eight steps with the highest absolute CiRP values A sensitivity analysis for the system variables was made at the RP For this, we initialized all variables in the model at their concentrations at RP, except for one variable to which we made a small perturbation A subsequent simulation was analyzed with respect to cell cycle completion, (i.e testing whether the perturbation made to the one variable could prevent RP) The perturbation that we made to the variable was to change its value to a value it had just before RP (i.e followed its integration path back in time) In this way, we determined the minimal time period that a variable must be regressed from RP along its time integration in order to stall the cell cycle progression From this analysis, it was evident that the RP was most sensitive for changes made to the cyclin E/Cdk2:p27 complex; changing its value to the value it had 0.04 s before the RP resulted in the cells entering quiescence The species with values that needed to be regressed 0.5 s or less to prevent RP are listed in Table 2; each of these variables also showed a good correlation in Fig The six metabolites for which RP showed a high sensitivity each had a different gradient in the correla- FEBS Journal 277 (2010) 357–367 ª 2009 The Authors Journal compilation ª 2009 FEBS R Conradie et al Restriction point control of the mammalian cell cycle Fig Correlation plots for concentration control coefficients and restriction point (RP) control Species that demonstrated a good correlation between their concentration control coefficients and RP control coefficients are shown in the top nine figure parts To illustrate the contrast, we also show plots for three species that did not show a good correlation in the bottom figure parts CE, cyclin E/Cdk2:p27 Table Species-dependent regression time necessary for cells to enter quiescence The six molecular intermediates for which the RP showed the highest sensitivity were each regressed in time (at the same time as initializing all other intermediates at their RP concentrations) until, upon subsequent simulation, the cells enter quiescence This minimal time that a species must be regressed to prevent RP is listed as the Regression time in the table The RP concentration and the percentage change in concentration of the intermediate concentration at the regression time point compared to the RP are also given AU, arbitrary units Species Regression time (s) % Change in concentration Concentration at RP (AU) CE CA p27 E2F CYCE Rb 0.04 0.18 0.22 0.22 0.47 0.54 0.0003 0.004 )0.001 0.004 0.007 )0.009 0.48 0.02 0.86 0.35 0.01 0.27 tion plots (Fig 4); for some intermediates, the correlation was positive, whereas, for others, it was negative, and each had a different slope The correlations observed in Fig suggest that several of the intermediates also correlate with one another (independent of which reaction is perturbed) Such covariances between intermediates make it difficult to asses a causal relationship The RP showed the highest sensitivity for changes in the concentration of cyclin E/Cdk2:p27 (Table 2); all of the other species needed to be perturbed more, either in terms of time regression or in terms of the percentage change in their concentrations This high sensitivity indicates that this intermediate is important for the regulation of RP, and we tested whether the difference in slopes in the correlation plots could be related to co-correlations between the intermediates and cyclin E/Cdk2:p27 For this, we first determined the co-control coefficients of cyclin E/Cdk2:p27 with the nine intermediates that showed a good correlation in Fig A co-control coefficient is defined as the ratio of two concentration control coefficients and quantifies the correlation between the two intermediates upon a small perturbation of a reaction step [25] Interestingly, the values for the co-control coefficients were largely independent of FEBS Journal 277 (2010) 357–367 ª 2009 The Authors Journal compilation ª 2009 FEBS 363 Restriction point control of the mammalian cell cycle R Conradie et al the reaction step that was perturbed, (i.e two intermediates would co-vary, independent of which step was perturbed) Thus, the co-control coefficients of the model species with the cyclin E/Cdk2:p27 complex quantify the extent that these species co-vary with the complex For example, cyclin E/Cdk2 (CYCE) and cyclin E/Cdk2:p27 (CE) showed a positive co-variation, with a co-control coefficient i OCYCE of 0.53, indicating CE that changes in the concentration of CE were correlated with approximately half the concentration change in CYCE By contrast, CE concentration is negatively correlated with p27Kip1 concentration (i.e if one goes up, the other goes down) quantitatively expressed in a co-control coefficient, i Op27 of )1.2 CE Subsequently, we calculated the ratio of the gradients in the correlation plots (Fig 4) for the intermediates, and for cyclin E/Cdk2:p27 For each of the intermediates, the ratio of its gradient in the correlation plot and the gradient of cyclin E/Cdk2:p27 was close to the value of the co-control coefficient of the intermediate with cyclin E/Cdk2:p27 For example, the gradient ratio for cyclin E/Cdk2 and cyclin E/Cdk2:p27 equals 0.49 and, for p27Kip1 and cyclin E/Cdk2:p27, the ratio equals )1.1 (these values are close to the respective co-control coefficients 0.53 and )1.2 as calculated above) This result is in agreement with the hypothesis that the correlations observed in Fig 4, between changes in system intermediate concentrations and RP, can be accounted for by co-correlations of those intermediates with cyclin E/Cdk2:p27 The observation that cyclin E/Cdk2:p27 needed to be regressed for the shortest time period (Table 2) indicated that this molecular species on its own could prevent RP Regressing any of the other species further back in time could potentially effect RP indirectly via cyclin E/Cdk2:p27 We further tested this by analyzing the effect on the cyclin E/Cdk2:p27 concentration upon perturbing each of the other variables to which the RP showed a high sensitivity Indeed, as can be seen in Fig 5A, changing any of these variables to such an extent that they interfered with the RP did lead to a change in cyclin E/Cdk2:p27 Each of the curves in Fig 5A is the result of a separate time simulation for the cyclin E/Cdk2:p27 concentration upon a perturbation of the indicated (red circle) model variable The wt curve is the reference curve where no perturbation was made The time point (x-axis value) corresponding with the red symbols indicates RP From Fig 5, it can be seen that the shift brought about to the RP was in very good agreement with the extent that the concentration of cyclin E/Cdk2:p27 was affected by the perturbation, for most metabolite perturbations, RP was shifted to 364 A 2.0 2.2 2.4 2.6 2.8 2.0 2.2 2.4 2.6 2.8 B Fig Control of the RP via the cyclin E/Cdk2:p27 For each of the six species towards which RP showed a high sensitivity (Table 2), a perturbation was made to its concentration such that it would affect RP, whereas all other variables where initialized with their RP concentrations The results of the subsequent time integrations, following the cyclin E/Cdk2:p27 concentration and the occurrence of RP, are plotted in (A), with the points denoting the time point of RP (x-axis) and the concentration of cyclin E/Cdk2:p27 (y-axis) For each simulation, the perturbed variable is indicated (B) The results of similar integrations are shown, subsequent to perturbation of the eight reactions that had a high RP control the time point where the cyclin E/Cdk2:p27 complex reached a critical concentration Because a causal relationship between the cyclin E/Cdk2:p27 concentration and the RP would necessitate that, for each perturbation of the complex, the RP must shift accordingly, we perturbed all reaction steps with a high control on RP and plotted the occurrence of RP together with the trajectory for cyclin E/Cdk2:p27 (Fig 5B) The reactions that were perturbed for each of the curves in Fig are indicated by number (corresponding to the numbers in Fig 1) Again, a very good correlation, in excellent agreement with the shift in RP upon metabolite perturbations, was observed for the reaction perturbations The correlation plots along with the sensitivity analysis are indicative of a causal rela- FEBS Journal 277 (2010) 357–367 ª 2009 The Authors Journal compilation ª 2009 FEBS R Conradie et al tionship between the cyclin E/Cdk2:p27 concentration and RP; independent of the type of perturbation made, a critical cyclin E/Cdk2:p27 concentration must be reached for RP transition The method presented here, combining control analysis with sensitivity analysis, and showing that all perturbations work via the same mechanism, comprises a generic method to test for causal relationships We illustrate the method for RP control in the Novak and Tyson model and the results obtained clearly indicate that the control of RP runs mostly via cyclin E/Cdk2:p27 Newer models have been constructed for the RP [4,9] but such models not describe the complete cell cycle Using a core model and experimental data of individual gene expression levels, Yao et al [4] demonstrated that the interplay between retinoblastoma and E2F creates a bistable switch that probably regulates the RP Although p27 was not modeled explicitly in this core model (its importance was stated in the text), there is still a strong similarity between the reactions that control RP, together with the feedback loops from cyclin D and cyclin E, in our model and the reactions involved in the bistable switch in the Yao model Thus, according to our analysis of the model of Novak and Tyson, taken together with the summation theorem, the interplay between retinoblastoma and E2F creates a bistable switch that has a strong effect on the RP, but with a net positive control (i.e advancing the RP), which is countered by the reactions affecting p27 (i.e delaying the RP) RP control in cancer cells Deregulation of the RP is implicated in almost all tumor cells and it has been suggested that regulation of the RP is essential to prevent cells from becoming cancerous [1] We thus investigated whether the species shown by our analysis to alter the RP were indeed implicated in malignancies in mammals Comparing phenotypic observations of tumor cells with the results of our analysis, we indeed observed that changes to cells lines leading to an increased concentration of cyclin E/Cdk2:p27 concentration, such as cyclin E overexpression [26–29] and p27Kip1 downregulation [28–32], yielded uncontrolled tumour proliferation in a wide range of human tissues Furthermore, it was observed that, in aggressive stomach, prostate, breast, lung and pituitary cancers, p27Kip1 levels were low, either as a result of degradation or translocation to the cytoplasm [33,34] These observations are in agreement with our co-control analysis; the co-control coefficients, Restriction point control of the mammalian cell cycle OCYCE ¼ 0:53 and i Op27 ¼ À1:2 quantify a strong posiCE CE tive correlation between cyclin E and cyclin E/Cdk2:p27 and a strong negative correlation between p27 and cyclin E/Cdk2:p27, where these co-control coefficients are largely independent of which step is perturbed These observations and model analyses lead us to hypothesize that RP is advanced in cancer cell lines as a result of an increased concentration of cyclin E/Cdk2:p27 Even though the Novak and Tyson model does not explicitly model the localization of p27 from the nucleus to the cytoplasm (i.e the transport of p27 from the nucleus is implicit in the reaction that RP degrades p27; Reaction 15, C15 $ À1), our results are consistent with the observation that the aggressiveness of cancer cells can be linked to a shift in the localization of p27 from the nucleus to the cytoplasm [34] As we have shown in our analysis, a decrease in the concentration of p27 is strongly correlated with an increase of the cyclin E/Cdk2:p27 concentration, which will advance the RP This is in agreement with the apparent absence of RP in cancer cells, which might be translated as advancing RP to such an extent that it never prevents G1/S transition The relatively high negative control of the consumption reaction of p27 RP (Reaction 15, C15 $ À1) is also in agreement with experiments showing that a reduction in p27 levels promotes the passage of the RP [35] i Conclusions In cancer cells, RP control appears to be completely absent On the basis of an extensive analysis of a detailed kinetic model, we hypothesize that such a shift of the RP to a much earlier point in the cell cycle might be caused by an increased concentration in the cyclin E/Cdk2:p27 complex concentration We showed that a perturbation of cyclin E/Cdk2:p27 on its own was sufficient to shift the RP In addition, we showed that the effect on RP upon perturbating any of the reaction steps could always be explained via a change in the cyclin E/Cdk2:p27 concentration, leading to the proposal that RP control by the reaction steps works via the cyclin E/Cdk2:p27 complex The method that we have used to quantify the control of a reaction step on any of the systems variables can be used to identify the reaction steps that would have the biggest effect on the cyclin E/Cdk2:p27 concentration and thereby shift RP most strongly An important implication is that it should be possible to shift RP in cancer cells back to its normal point via perturbations of steps that effect the cyclin E/Cdk2:p27 concentration FEBS Journal 277 (2010) 357–367 ª 2009 The Authors Journal compilation ª 2009 FEBS 365 Restriction point control of the mammalian cell cycle R Conradie et al Acknowledgements R.C and J.L.S acknowledge the National Bioinformatics Network (South Africa) for funding and support for the JWS Online project F.J.B thanks the Netherlands Institute for Systems Biology and NWO for funding A.C acknowledges support from the Italian research fund FIRB (project RBPR0523C3) B.N thanks UNICELLSYS, YSBN and BBSRC for funding H.V.W thanks EC-FPs BioSim, EC-MOAN, NucSys, UNICELLSYS, YSBN, ESF-FuncDyn, NWO-FALW and the BBSRC and EPSRC for support References Pardee A (1974) A restriction point for control of normal animal cell proliferation Proc Natl Acad Sci USA 71, 1286–1290 Planas-Silva MD, Weinberg RA (1997) The restriction point and control of cell proliferation Current Opin Cell Biol 9, 768–772 Blagosklonny MV & Pardee AB (2002) The restriction point of the cell cycle Cell Cycle 1, 103–110 Yao G & Lee TJ, Mori S, Nevins JR & You L (2008) A bistable Rb-E2F switch underlies the restriction point Nat Cell Biol 10, 476–482 Novak B & Tyson J (2004) A model for restriction point control of the mammalian cell cycle J Theor Biol 230, 563–579 Barberis M, Klipp E, Vanoni M & Alberghina L (2007) Cell size at S phase initiation: an emergent property of the G1/S network PLoS Comput Biol 3, e64, doi:10.1371/journal.pcbi.0030064 Hatzimanikatis V, Lee KH & Bailey JE (1999) A mathematical description of regulation of the G1-S transition of the mammalian cell cycle Biotechnol Bioeng 65, 631–637 Aguda B & Tang Y (1999) The kinetic origins of the restriction point in the mammalian cell cycle Cell Prolifer 32, 321335 Haberichter T, Madge B, Christopher RA, Yoshioka ă N, Dhiman A, Miller R, Gendelman R, Aksenov SV, Khalil IG, Dowdy SF et al (2007) A systems biology dynamical model of mammalian G1 cell cycle progression Mol Syst Biol 3, 84, doi:10.1038/msb4100126 10 Zetterberg A & Larsson O (1995) ‘Cell cycle progression and growth in mammalian cells: kinetic aspects of transition events’ In Cell Cycle Control (Hutchison C & Glover DM, eds), pp 206–227 Oxford University Press, Oxford 11 Kacser H & Burns JA (1973) The control of flux Symp Soc Exp Biol 27, 65–104 12 Heinrich R & Rapoport TA (1974) A linear steady-state treatment of enzymatic chains General properties control, and effector strength Eur J Biochem 42, 89–95 366 13 Reijenga K, Westerhoff HV, Kholodenko BN & Snoep J (2002) Control analysis for autonomously oscillating biochemical networks Biophys J 82, 99–108 14 Ingalls B & Sauro H (2003) Sensitivity analysis of stoichiometric networks: an extension of metabolic control analysis to non-steady state trajectories J Theor Biol 222, 23–26 15 Kholodenko B, Demin O & Westerhoff H (1997) Control analysis of periodic phenomena in biological systems J Phys Chem B 101, 2070–2081 16 Demin O, Westerhoff H & Kholodenko B (1999) Control analysis of stationary forced oscillations J Phys Chem B 103, 10695–10710 17 Conradie R, Westerhoff H, Hofmeyr JH, Rohwer J & Snoep J (2006) Summation theorems for flux and concentration control coefficients of dynamic systems Syst Biol, IEE Proc 153, 314–317 18 Snoep JL & Westerhoff HV (2005) ‘From isolation to integration a systems biology approach for building the Silicon Cell’ In Systems Biology: Definitions and Perspectives (Alberghina L & Westerhoff HV, eds), p Springer-Verlag, Berlin ⁄ Heidelberg 19 Maddox J (1994) Cell-cycle regulation by numbers Nature 369, 437 20 Hartwell LH, Hopfield JJ, Leibler S & Murray AW (1999) From molecular to modular cell biology Nature 402, C47–C52 21 Lander ES & Weinberg RA (2000) Genomics: journey to the center of biology Science 287, 1777–1782 22 Nurse P (2000) The incredible life and times of biological cells Science 289, 1711–1716 23 Gilman A & Arkin AP (2002) Genetic ‘code’: representations and dynamical models of genetic components and networks Annu Rev Genomics Hum Genet 3, 341–369 24 Kumar S & Feidler JC (2003) BioSPICE: a computational infrastructure for integrative biology OMICS 7, 225 25 Hofmeyr JH & Cornish-Bowden A (1996) Co-response analysis: a new experimental strategy for metabolic control analysis J Theor Biol 182, 371–380 26 Skalicky DA, Kench JG, Segara D, Coleman MJ, Sutherland RL, Henshall SM, Musgrove EA & Biankin AV (2006) Cyclin E expression and outcome in pancreatic ductal adenocarcinoma Cancer Epidemiol Biomarkers Prev 15, 1941–1947 27 Schraml P, Bucher C, Bissig H, Nocito A, Haas P, Wilber K, Seelig S, Kononen J, Mihatsch MJ, Dirnhofer S, Dirnhofer S et al (2003) cyclin E overexpression and amplification in human tumours J Pathol 200(3), 375–382 28 Hayashi H, Ogawa N, Ishiwa N, Yazawa T, Inayama Y, Ito T & Kitamura H (2001) High cyclin E and low p27/Kip1 expressions are potentially poor rognostic factors in lung adenocarcinoma patients Lung Cancer 34, 59–65 FEBS Journal 277 (2010) 357–367 ª 2009 The Authors Journal compilation ª 2009 FEBS R Conradie et al 29 Tamiya T, Mizumatsu S, Ono Y, Abe T, Matsumoto K, Furuta T & Ohmoto T (2001) High cyclin E/low p27Kip1 expression is associated with poor prognosis in astrocytomas Acta Neuropathol 101, 334–340 30 Pizzo JJD, Borkowski A, Jacobs SC & Kyprianou N (1999) Loss of cell cycle regulators p27Kip1 and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival Am J Pathol 155, 1129–1136 31 Erlanson M, Portin C, Linderholm B, Lindh J, Roos G & Landberg G (1998) Expression of cyclin E and the cyclin-dependent kinase inhibitor p27 in malignant lymphomas-prognostic implications Blood 92, 770–777 Restriction point control of the mammalian cell cycle 32 Geisen C, Karsunky H, Yucel R & Moroy T (2003) Loss of p27Kip1 cooperates with cyclin E in T-cell lymphomagenesis Oncogene 22, 1724–1729 33 Zhou Q, He Q & Liang LJ (2003) Expression of p27 cyclin E and cyclin A in hepatocellular carcinoma and its clinical significance World J Gastroenterol 9, 2450–2454 34 Chu IM, Hengst L & Slingerland JM (2008) The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy Nat Rev Cancer 8, 253–267 35 Hitomi M, Yang K, Guo Y, Fretthold J, Harwalkar J & Stacey DW (2006) p27Kip1 and cyclin dependent kinase regulate passage through the restriction point Cell Cycle 5, 2281–2289 FEBS Journal 277 (2010) 357–367 ª 2009 The Authors Journal compilation ª 2009 FEBS 367 ... description of regulation of the G1-S transition of the mammalian cell cycle Biotechnol Bioeng 65, 631–637 Aguda B & Tang Y (1999) The kinetic origins of the restriction point in the mammalian cell cycle. .. the correlation plot and the gradient of cyclin E/Cdk2:p27 was close to the value of the co -control coefficient of the intermediate with cyclin E/Cdk2:p27 For example, the gradient ratio for cyclin. .. 2009 The Authors Journal compilation ª 2009 FEBS R Conradie et al A Restriction point control of the mammalian cell cycle C B D E F Fig The reaction network scheme of the mammalian cell cycle